GarrettLawlorMD

Gastroenterology • New York, NY

Inflammatory Bowel Disease

Assoc Director, Inflammatory Bowel Diseases Program - Columbia University Medical Center / NY-Presbyterian Hospital

Join to view full profile

Dr. Lawlor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lawlor's full profile

Already have an account?

Office
161 Fort Washington Ave, New York
Ste 862, 8th Floor
New York, NY 10032
Phone+1 212-305-5664

Fax+1 212-305-5576

Education & Training

University College of Dublin National Univ SOMClass of 2002

Certifications & Licensure

NY State Medical License 2014 - 2026
MA State Medical License 2011 - 2015

Publications & Presentations

PubMed

Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.
Bruce E Sands, David T Rubin, Edward V Loftus Jr, Douglas C Wolf, Remo Panaccione
The American Journal of Gastroenterology. 2025-01-08
2 citations
Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis.
Miguel Regueiro, Britta Siegmund, Sara Horst, Ryan Moslin, Lorna Charles
Inflammatory Bowel Diseases. 2024-07-17
13 citations
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label ...
Silvio Danese, Remo Panaccione, Maria T Abreu, David T Rubin, Subrata Ghosh
Journal of Crohn's & Colitis. 2024-02-26

Journal Articles

Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease
Andrew Joelson, Simon Lichtiger, Jordan E Axelrad, Garrett Lawlor, Benjamin Lebwohl, Nature